Beta Bionics Inc (NASDAQ:BBNX)’s traded shares stood at 0.45 million during the last session. At the close of trading, the stock’s price was $10.91, to imply an increase of 2.06% or $0.22 in intraday trading. The BBNX share’s 52-week high remains $24.50, putting it -124.56% down since that peak but still an impressive 18.52% since price per share fell to its 52-week low of $8.89. The company has a valuation of $472.95M, with an average of 0.6 million shares in intraday trading volume over the past 10 days and average of 647.07K shares over the past 3 months.
Beta Bionics Inc (NASDAQ:BBNX) trade information
After registering a 2.06% upside in the last session, Beta Bionics Inc (BBNX) has traded red over the past five days. The 5-day price performance for the stock is 10.09%, and -22.29% over 30 days. With these gigs, the year-to-date price performance is -53.83%. Short interest in Beta Bionics Inc (NASDAQ:BBNX) saw shorts transact 1.21 million shares and set a 3.43 days time to cover.
Beta Bionics Inc (BBNX) estimates and forecasts
The rating firms project that company’s revenue will grow 26.87% compared to the previous financial year.
Revenue forecast for the current quarter as set by 7 analysts is 16.15M. Meanwhile, for the current quarter, a total of 7 analyst(s) estimate revenue growth to 19.26M.
BBNX Dividends
Beta Bionics Inc has its next earnings report out on 2025-Mar-24. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Beta Bionics Inc (NASDAQ:BBNX)’s Major holders
Beta Bionics Inc insiders hold 6.84% of total outstanding shares, with institutional holders owning 52.21% of the shares at 56.04% float percentage. In total, 52.21% institutions holds shares in the company.
We also have AB CAP FUND, INC.-AB Small Cap Growth Portfolio and Legg Mason Global Asset Management Trust-ClearBridge Small Cap Fund as the top two Mutual Funds with the largest holdings of the Beta Bionics Inc (BBNX) shares. Going by data provided on Feb 28, 2025 , AB CAP FUND, INC.-AB Small Cap Growth Portfolio holds roughly 571.29 shares. This is just over 1.32% of the total shares, with a market valuation of $6.23 million. Data from the same date shows that the other fund manager holds a little less at 200.0, or 0.46% of the shares, all valued at about 2.18 million.
